Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Up 207.1% in January

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 4,300 shares, a growth of 207.1% from the December 31st total of 1,400 shares. Based on an average daily volume of 11,200 shares, the short-interest ratio is presently 0.4 days.

Invesco Nasdaq Biotechnology ETF Price Performance

NASDAQ:IBBQ traded up $0.17 on Thursday, reaching $22.65. 4,466 shares of the company’s stock were exchanged, compared to its average volume of 7,235. The stock has a fifty day simple moving average of $22.20 and a 200-day simple moving average of $23.25. The firm has a market cap of $40.09 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. Invesco Nasdaq Biotechnology ETF has a 52 week low of $20.14 and a 52 week high of $24.84.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Friday, December 27th. Shareholders of record on Monday, December 23rd were paid a dividend of $0.0619 per share. The ex-dividend date was Monday, December 23rd.

Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF

Several institutional investors and hedge funds have recently made changes to their positions in the business. Strategic Financial Concepts LLC purchased a new position in shares of Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at approximately $1,699,000. Mirae Asset Global Investments Co. Ltd. raised its position in Invesco Nasdaq Biotechnology ETF by 22.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after buying an additional 48,137 shares during the last quarter. Finally, ORG Partners LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the 3rd quarter valued at $25,000.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.